QQQ   444.17 (-0.15%)
AAPL   171.47 (-1.06%)
MSFT   420.25 (-0.28%)
META   487.97 (-1.19%)
GOOGL   150.76 (-0.07%)
AMZN   180.24 (+0.23%)
TSLA   176.61 (-1.79%)
NVDA   902.47 (+0.00%)
NIO   4.53 (-3.00%)
AMD   180.18 (+0.33%)
BABA   72.46 (+1.22%)
T   17.68 (+0.74%)
F   13.23 (+1.30%)
MU   117.55 (-1.33%)
CGC   9.10 (-4.71%)
GE   175.00 (-2.84%)
DIS   122.57 (+1.31%)
AMC   3.69 (-14.98%)
PFE   28.06 (+1.01%)
PYPL   67.21 (+0.96%)
XOM   116.07 (+0.96%)
QQQ   444.17 (-0.15%)
AAPL   171.47 (-1.06%)
MSFT   420.25 (-0.28%)
META   487.97 (-1.19%)
GOOGL   150.76 (-0.07%)
AMZN   180.24 (+0.23%)
TSLA   176.61 (-1.79%)
NVDA   902.47 (+0.00%)
NIO   4.53 (-3.00%)
AMD   180.18 (+0.33%)
BABA   72.46 (+1.22%)
T   17.68 (+0.74%)
F   13.23 (+1.30%)
MU   117.55 (-1.33%)
CGC   9.10 (-4.71%)
GE   175.00 (-2.84%)
DIS   122.57 (+1.31%)
AMC   3.69 (-14.98%)
PFE   28.06 (+1.01%)
PYPL   67.21 (+0.96%)
XOM   116.07 (+0.96%)
QQQ   444.17 (-0.15%)
AAPL   171.47 (-1.06%)
MSFT   420.25 (-0.28%)
META   487.97 (-1.19%)
GOOGL   150.76 (-0.07%)
AMZN   180.24 (+0.23%)
TSLA   176.61 (-1.79%)
NVDA   902.47 (+0.00%)
NIO   4.53 (-3.00%)
AMD   180.18 (+0.33%)
BABA   72.46 (+1.22%)
T   17.68 (+0.74%)
F   13.23 (+1.30%)
MU   117.55 (-1.33%)
CGC   9.10 (-4.71%)
GE   175.00 (-2.84%)
DIS   122.57 (+1.31%)
AMC   3.69 (-14.98%)
PFE   28.06 (+1.01%)
PYPL   67.21 (+0.96%)
XOM   116.07 (+0.96%)
QQQ   444.17 (-0.15%)
AAPL   171.47 (-1.06%)
MSFT   420.25 (-0.28%)
META   487.97 (-1.19%)
GOOGL   150.76 (-0.07%)
AMZN   180.24 (+0.23%)
TSLA   176.61 (-1.79%)
NVDA   902.47 (+0.00%)
NIO   4.53 (-3.00%)
AMD   180.18 (+0.33%)
BABA   72.46 (+1.22%)
T   17.68 (+0.74%)
F   13.23 (+1.30%)
MU   117.55 (-1.33%)
CGC   9.10 (-4.71%)
GE   175.00 (-2.84%)
DIS   122.57 (+1.31%)
AMC   3.69 (-14.98%)
PFE   28.06 (+1.01%)
PYPL   67.21 (+0.96%)
XOM   116.07 (+0.96%)
OTCMKTS:INNV

InnovAge (INNV) Stock Price, News & Analysis

$4.34
+0.10 (+2.36%)
(As of 03/27/2024 ET)
Today's Range
$4.30
$4.65
50-Day Range
$4.24
$5.89
52-Week Range
$3.96
$8.15
Volume
11,944 shs
Average Volume
22,559 shs
Market Capitalization
$589.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

InnovAge MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
61.3% Upside
$7.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.25) to ($0.05) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.12 out of 5 stars

INNV stock logo

About InnovAge Stock (OTCMKTS:INNV)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

INNV Stock Price History

INNV Stock News Headlines

AI Bubble Now at Critical Mass
Washington, D.C., has just issued its first round of new artificial-intelligence (“AI”) regulations. And a flood of additional AI bills is making its way through Congress. Nasdaq reports this could bring a screeching halt to the AI stock boom.
Car-sharing company Getaround cuts one-third of US workforce
Singapore Takes Large Stake in Kohl’s
8 Purchases Boomers Should Never Make During Retirement
AI Bubble Now at Critical Mass
Washington, D.C., has just issued its first round of new artificial-intelligence (“AI”) regulations. And a flood of additional AI bills is making its way through Congress. Nasdaq reports this could bring a screeching halt to the AI stock boom.
InnovAge to Host Investor Day on February 27, 2024
Earnings Outlook For InnovAge Holding
Earnings Preview: InnovAge Holding
INNVInnovAge Holding Corp.
See More Headlines
Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/06/2024
Today
3/28/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
Current Symbol
OTCMKTS:INNV
Previous Symbol
NASDAQ:INNV
Fax
N/A
Employees
2,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$7.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+61.3%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-6,520,000.00
Pretax Margin
-7.63%

Debt

Sales & Book Value

Annual Sales
$720.80 million
Cash Flow
$0.07 per share
Book Value
$2.50 per share

Miscellaneous

Free Float
135,311,000
Market Cap
$589.80 million
Optionable
Not Optionable
Beta
0.16
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Patrick Blair (Age 53)
    President & CEO
    Comp: $1.51M
  • Ms. Nicole D'Amato (Age 45)
    Chief Legal Officer & Corporate Secretary
    Comp: $678.76k
  • Dr. Richard A. Feifer FACP (Age 57)
    M.D., M.P.H., Chief Medical Officer
    Comp: $588.97k
  • Mr. Edward Moore Kennedy Jr. (Age 63)
    J.D., Independent Director
    Comp: $100k
  • Hon. Marilyn Barbour Tavenner M.H.A. (Age 62)
    R.N., Independent Director
    Comp: $120k
  • Mr. Benjamin Crowninshield Adams (Age 60)
    Chief Financial Officer
  • Ms. Christine Bent (Age 53)
    Chief Operations Officer
  • Ms. Cara Babachicos
    Chief Information Officer
  • Mr. Ryan Kubota
    Director of Investor Relations
  • Ms. Olivia Patton
    Chief Compliance Officer

INNV Stock Analysis - Frequently Asked Questions

What is InnovAge's stock price target for 2024?

0 brokerages have issued twelve-month target prices for InnovAge's shares. Their INNV share price targets range from $7.00 to $7.00. On average, they predict the company's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 61.3% from the stock's current price.
View analysts price targets for INNV
or view top-rated stocks among Wall Street analysts.

How have INNV shares performed in 2024?

InnovAge's stock was trading at $6.00 at the beginning of the year. Since then, INNV stock has decreased by 27.7% and is now trading at $4.34.
View the best growth stocks for 2024 here
.

How were InnovAge's earnings last quarter?

InnovAge Holding Corp. (OTCMKTS:INNV) released its earnings results on Tuesday, February, 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.03). The business earned $188.90 million during the quarter, compared to the consensus estimate of $181.51 million. InnovAge had a negative net margin of 6.17% and a negative trailing twelve-month return on equity of 13.04%.

What other stocks do shareholders of InnovAge own?
How do I buy shares of InnovAge?

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:INNV) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners